Conference
    
• ID Number 1910
• Aug 31, 2023
• 202
               

12th Annual Hybrid Case Based Approach to Controversies in Cardiovascular Diseases

The Conference is co- sponsored by Cleveland Clinic and Mayo Clinic and will offer the most-timely updates on significant advances in prevention, diagnosis, and treatment of cardiovascular diseases. All topics will be presented in a Real World case-based format which encourages participation and debate between the faculty and attendees. https://cvuae.com/ Target Audience Cardiologists & Cardiac Surgeons Fellows and Residents in Cardiovascular and Cardiac Surgery training programs Nurses, Physician Assistants and other Allied Health Professionals involved in the care of cardiovascular patients Medical students with an interest in Cardiovascular Medicine Internists & General Practitioners Learning Objectives Be apprised on how to incorporate the most recent advances in cardiovascular medicine into disease prevention and management strategies Identify cardiovascular disease risk factors in patients without known coronary artery disease , and how to use them to predict the risk of future coronary events Appreciate what is optimal medical therapy and the therapeutic targets for management of cardiovascular diseases Appreciate the most recent developments in the evaluation and management of patients with heart failure, valvular and coronary artery disease Become familiar with the newest transcatheter and surgical techniques in the management of cardiovascular diseases including valvular heart diseases, coronary artery disease, and the cardiomyopathies. Critically appraise state of the art management strategies in endocarditis. Upon completion of the conference, participants should know how to apply current cardiovascular treatment algorithms in their daily practice, and how to navigate the intricacies of complex and challenging cardiovascular problems Registration Link: https://cvuae.com/#registration Social Media: https://www.facebook.com/CVConfUAE/ https://www.instagram.com/CVConfUAE/ https://twitter.com/CVConfUAE/